RYTM · All filings · Read this filing
What changed 10-Q
Item 5. Other Information
2021-08-03 compared with 2021-05-03 · 3 added, 1 removed, 25 unchanged (14% of the section changed)
4 unchanged sentences
Amended and Restated Bylaws.
−Removed: Summary of Non-Employee Director Compensation Policy.
+Added: Offer Letter, dated July 9, 2021, by and between the Registrant and Pamela Cramer.
Certification of the Principal Executive Officer, as required by Section 302 of the Sarbanes-Oxley Act of 2002 (18 U.S.C.
13 unchanged sentences
RHYTHM PHARMACEUTICALS, INC.
+Added: August 3, 2021
President and Chief Executive Officer
(Principal Executive Officer)
+Added: August 3, 2021
/s/ Hunter C.
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.